Life Science Investing Sernova Biotherapeutics Announces $13 Million Debt-to-Equity Conversion Eliminating Significant Financing Overhang
Life Science Investing Sernova Biotherapeutics Appoints John L. Brooks III, Former Chair and CEO of Joslin Diabetes Research Center, as Chair of the Board of Directors
Life Science Investing Sernova Biotherapeutics to Participate in the H.C. Wainwright 27th Annual Global Investor Conference
Westport Reveals CNG Solution for Natural Gas HPDI Engines and North America's Clean Transportation Future
Heliostar Announces PEA for Ana Paula Underground with Strong Economics and Sustainable Cash Generation
